TR199800406T1 - Alipoprotein A-I d�zeylerinin artt�r�lmas� i�in bir tienotriazolodiazepinin kullan�lmas�. - Google Patents

Alipoprotein A-I d�zeylerinin artt�r�lmas� i�in bir tienotriazolodiazepinin kullan�lmas�.

Info

Publication number
TR199800406T1
TR199800406T1 TR1998/00406T TR9800406T TR199800406T1 TR 199800406 T1 TR199800406 T1 TR 199800406T1 TR 1998/00406 T TR1998/00406 T TR 1998/00406T TR 9800406 T TR9800406 T TR 9800406T TR 199800406 T1 TR199800406 T1 TR 199800406T1
Authority
TR
Turkey
Prior art keywords
lmas
pct
zeylerinin
tienotriazolodiazepinin
kullan
Prior art date
Application number
TR1998/00406T
Other languages
English (en)
Turkish (tr)
Inventor
Kempen Herman
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of TR199800406T1 publication Critical patent/TR199800406T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TR1998/00406T 1995-09-09 1996-08-30 Alipoprotein A-I d�zeylerinin artt�r�lmas� i�in bir tienotriazolodiazepinin kullan�lmas�. TR199800406T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95114163 1995-09-09

Publications (1)

Publication Number Publication Date
TR199800406T1 true TR199800406T1 (en) 1998-05-21

Family

ID=8219597

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/00406T TR199800406T1 (en) 1995-09-09 1996-08-30 Alipoprotein A-I d�zeylerinin artt�r�lmas� i�in bir tienotriazolodiazepinin kullan�lmas�.

Country Status (14)

Country Link
US (1) US5854238A (cg-RX-API-DMAC10.html)
EP (1) EP0853480B1 (cg-RX-API-DMAC10.html)
JP (1) JPH11512107A (cg-RX-API-DMAC10.html)
KR (1) KR19990044460A (cg-RX-API-DMAC10.html)
CN (1) CN1101680C (cg-RX-API-DMAC10.html)
AT (1) ATE230600T1 (cg-RX-API-DMAC10.html)
AU (1) AU725249B2 (cg-RX-API-DMAC10.html)
BR (1) BR9610390A (cg-RX-API-DMAC10.html)
CA (1) CA2230477A1 (cg-RX-API-DMAC10.html)
DE (1) DE69625696T2 (cg-RX-API-DMAC10.html)
DK (1) DK0853480T3 (cg-RX-API-DMAC10.html)
ES (1) ES2188783T3 (cg-RX-API-DMAC10.html)
TR (1) TR199800406T1 (cg-RX-API-DMAC10.html)
WO (1) WO1997009048A1 (cg-RX-API-DMAC10.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518412B1 (en) * 1997-09-29 2003-02-11 Jean-Louis Dasseux Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6004925A (en) * 1997-09-29 1999-12-21 J. L. Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6253569B1 (en) * 1999-05-07 2001-07-03 James J. Hall Portable storage unit for game animals
US7723303B2 (en) 2000-08-24 2010-05-25 The Regents Of The University Of California Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
US7166578B2 (en) 2000-08-24 2007-01-23 The Regents Of The University Of California Orally administered peptides synergize statin activity
US7148197B2 (en) * 2000-08-24 2006-12-12 The Regents Of The University Of California Orally administered small peptides synergize statin activity
US7199102B2 (en) * 2000-08-24 2007-04-03 The Regents Of The University Of California Orally administered peptides synergize statin activity
US7144862B2 (en) 2000-08-24 2006-12-05 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US6664230B1 (en) 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US8568766B2 (en) 2000-08-24 2013-10-29 Gattadahalli M. Anantharamaiah Peptides and peptide mimetics to treat pathologies associated with eye disease
US8124625B2 (en) 2001-09-14 2012-02-28 Shionogi & Co., Ltd. Method of enhancing the expression of apolipoprotein AI using olefin derivatives
US7429593B2 (en) 2001-09-14 2008-09-30 Shionogi & Co., Ltd. Utilities of amide compounds
US20040235877A1 (en) 2001-09-14 2004-11-25 Natsuki Ishizuka Novel use of tricyclic compound
US6930085B2 (en) 2002-04-05 2005-08-16 The Regents Of The University Of California G-type peptides to ameliorate atherosclerosis
KR20070089996A (ko) 2004-12-06 2007-09-04 더 리전트 오브 더 유니버시티 오브 캘리포니아 세동맥의 구조 및 기능의 개선 방법
JP2010538005A (ja) 2007-08-28 2010-12-09 ユーエービー リサーチ ファウンデーション 合成アポリポ蛋白質ｅ模倣ポリペプチドおよび使用方法
AU2008296487A1 (en) 2007-08-28 2009-03-12 The Uab Research Foundation Synthetic apolipoprotein E mimicking polypeptides and methods of use
CN102292341B (zh) * 2008-10-30 2014-09-10 环行医学有限责任公司 对apo a有活性的噻吩并三唑并二氮杂*衍生物
CN103154246B (zh) 2010-05-14 2015-11-25 达那-法伯癌症研究所 用于治疗白血病的组合物和方法
ES2606958T3 (es) 2010-05-14 2017-03-28 Dana-Farber Cancer Institute, Inc. Compuestos de tienotriazolodiazepina para tratar una neoplasia
WO2011143651A1 (en) * 2010-05-14 2011-11-17 Dana-Farber Cancer Institute, Inc. Compositions and methods for modulating metabolism
CN103180318B (zh) 2010-05-14 2017-05-10 达那-法伯癌症研究所 雄性避孕组合物以及使用方法
BR112016001457A2 (pt) 2013-07-25 2017-08-29 Dana Farber Cancer Inst Inc Inibidores de fatores de transcrição e usos dos mesmos
US11446309B2 (en) 2013-11-08 2022-09-20 Dana-Farber Cancer Institute, Inc. Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors
EP3099693A4 (en) 2014-01-31 2017-08-16 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
MX2016009974A (es) 2014-01-31 2016-10-31 Dana Farber Cancer Inst Inc Derivados de diaminopirimidina bencensulfona y sus usos.
WO2015131113A1 (en) 2014-02-28 2015-09-03 Tensha Therapeutics, Inc. Treatment of conditions associated with hyperinsulinaemia
JP7081923B2 (ja) 2014-07-31 2022-06-07 ユーエイビー リサーチ ファンデーション アポｅ模倣ペプチド及び血漿コレステロールを取り除くためのより高い効果
WO2016022970A1 (en) 2014-08-08 2016-02-11 Dana-Farber Cancer Institute, Inc. Dihydropteridinone derivatives and uses thereof
RU2017104897A (ru) 2014-08-08 2018-09-10 Дана-Фарбер Кэнсер Инститьют, Инк. Производные диазепана и их применения
UA122130C2 (uk) 2014-10-27 2020-09-25 Тенша Терапеутікс, Інк. Інгібітори бромодомену
CA2986441A1 (en) 2015-06-12 2016-12-15 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
RU2018112953A (ru) 2015-09-11 2019-10-14 Дана-Фарбер Кэнсер Инститьют, Инк. Ацетамидтиенотриазолодиазепины и пути их применения
US11306105B2 (en) 2015-09-11 2022-04-19 Dana-Farber Cancer Institute, Inc. Cyano thienotriazolodiazepines and uses thereof
CR20180336A (es) 2015-11-25 2018-08-06 Dana Farber Cancer Inst Inc Inhibidores de bromodominio bivalentes y usos de los mismos
EA202092635A1 (ru) 2018-06-13 2021-03-23 Дибли Аг Получение конденсированных производных триазепина и их применение в качестве ингибиторов bet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12303A (en) * 1973-02-08 1979-01-16 Hoffmann La Roche Thienotriazolodiazepine derivatives
US4155913A (en) * 1973-02-08 1979-05-22 Hoffmann-La Roche Inc. Thienotriazolodiazepine derivatives
JPS50100096A (cg-RX-API-DMAC10.html) * 1974-01-08 1975-08-08

Also Published As

Publication number Publication date
AU725249B2 (en) 2000-10-12
BR9610390A (pt) 1999-07-06
DE69625696D1 (de) 2003-02-13
CN1101680C (zh) 2003-02-19
EP0853480A1 (en) 1998-07-22
US5854238A (en) 1998-12-29
EP0853480B1 (en) 2003-01-08
ES2188783T3 (es) 2003-07-01
WO1997009048A1 (en) 1997-03-13
KR19990044460A (ko) 1999-06-25
DK0853480T3 (da) 2003-05-05
CN1195989A (zh) 1998-10-14
MX9801753A (es) 1998-08-30
ATE230600T1 (de) 2003-01-15
CA2230477A1 (en) 1997-03-13
AU6930396A (en) 1997-03-27
JPH11512107A (ja) 1999-10-19
DE69625696T2 (de) 2003-10-16

Similar Documents

Publication Publication Date Title
ATE230600T1 (de) Verwendung eines thienotriazoldiazepins zur erhöhung des apolopoproteins a-i niveaus
IL124674A0 (en) Piperazine derivatives pharmaceutical compositions containing the same and use thereof
CA2174494A1 (en) Benzofurans
NZ290420A (en) Phenyl or pyridyl-amide substituted dihydro benzofurans; medicaments
BR9710994A (pt) Derivados anticonvulsivos úteis no tratamento de obesidade.
BG103190A (en) Substituted pyrimidine derivatives and their pharmaceutical application
IL143748A0 (en) Substituted aryl or heteroarylamides having retinoid-like biological activity
CY2476B1 (en) Benzonaphthyridines as bronchial therapeutics.
AU6617596A (en) Cyclo-oxygenase inhibitor and amidine derivative salts, their preparation process, their use as medicaments, and pharmaceutical compositions containing them
AU694292B2 (en) Process for deactivating or destroying microorganisms
ZA964097B (en) New variant of apolipoprotein a-i
AU4623396A (en) 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
MX9701816A (es) Cepas de bacterias y composicion farmaceutica que contiene dichas cepas y uso de la misma para prevenir y tratar enfermedades asociadas con el metabolismo alterado de acidos biliares o causadas por el mismo.
GB9515279D0 (en) Improved therapeutic agents
IL122606A0 (en) (S)-hydroxy-nitrile-lyase
CA2098842A1 (en) Use of host cell phospholipids for inhibiting microbial colonization
NZ320259A (en) Deodorizing preparations containing cationic biopolymers, aluminium hydrochlorate and esterase inhibitors
AU3166295A (en) Imidazopyridine-azolidinones
AU6700996A (en) Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone
AU1875395A (en) 4-amino derivatives of 5-substituted mycophenolic acid
BG101983A (en) Substituted phenylamidines, medicamentous forms containing them and mehtod for their preparation
DE59712297D1 (de) 3-alkylimidazopyridine
DE69814401D1 (de) 2,3-benzodiazepin-derivate
MX9800053A (es) Herbicidas de cis-2,3-expoxicicloalcanol bencilado.
GB9801913D0 (en) Protection against pathogenic microorganisms